- Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
-
Paik ES, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS
- KMID: 2363318
- J Gynecol Oncol.
- 2016 May;27(3):e24.
- doi: 10.3802/jgo.2016.27.e24
OBJECTIVE: To assess the feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer (EOC) by comparing its outcomes to those of laparotomy. METHODS: We performed retrospective analysis in... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of aggressive surgical cytoreduction in advanced ovarian cancer
-
Chang SJ, Bristow RE, Chi DS, Cliby WA
- KMID: 2345925
- J Gynecol Oncol.
- 2015 Oct;26(4):336-342.
- doi: 10.3802/jgo.2015.26.4.336
Ovarian cancer is the eighth most frequent cancer in women and is the most lethal gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly diagnosed presenting with advanced-stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study
-
Elzarkaa A, Shaalan W, Elemam D, Mansour H, Melis M, Malik E, Soliman AA
- KMID: 2417437
- J Gynecol Oncol.
- 2018 Jul;29(4):e47.
- doi: 10.3802/jgo.2018.29.e47
OBJECTIVE: A numerical score, the peritoneal cancer index (PCI), was developed to reflect the extent of tumor growth in gastric and colorectal cancers and to tailor treatment. This study aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
-
Carbajal-Mamani SL, Schweer D, Markham MJ, Esnakula A, Grajo JR, Castagno J, Cardenas-Goicoechea J
- KMID: 2471752
- Obstet Gynecol Sci.
- 2020 Mar;63(2):150-157.
- doi: 10.5468/ogs.2020.63.2.150
OBJECTIVE: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine... -
- CITED
-
- Close
- SHARE
-
- Close
- A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
-
Bogani G, Tagliabue , Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci , Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2409941
- J Gynecol Oncol.
- 2018 May;29(3):e40.
- doi: 10.3802/jgo.2018.29.e40
OBJECTIVE: To test the applicability of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Memorial Sloan Kettering (MSK) criteria in predicting complete cytoreduction (CC) in patients undergoing secondary cytoreductive surgery (SCS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic value of integrated ¹â¸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
-
Lee YJ, Kim YM, Jung PS, Lee JJ, Kim JK, Kim YT, Nam JH
- KMID: 2409937
- J Gynecol Oncol.
- 2018 May;29(3):e36.
- doi: 10.3802/jgo.2018.29.e36
OBJECTIVE: The aim of this study was to evaluate the diagnostic value of integrated 18F-fluoro-2-deoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) for suspected recurrence of epithelial ovarian cancer (EOC) with non-disseminated lesions. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
-
Bogani G, Leone Roberti Maggiore U, Paolini B, Diito A, Martinelli F, Lorusso D, Raspagliesi F
- KMID: 2429573
- J Gynecol Oncol.
- 2019 Jan;30(1):e4.
- doi: 10.3802/jgo.2019.30.e4
OBJECTIVE: To examine outcomes of patients having treatments for newly diagnosed advanced stage low-grade serous ovarian cancer (LGSC). METHODS: We conducted a retrospective case series of women affected by advanced stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
-
Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M
- KMID: 2457137
- J Gynecol Oncol.
- 2019 Mar;30(2):e25.
- doi: 10.3802/jgo.2019.30.e25
OBJECTIVE: To assess the morbidity associate with rectosigmoid resection (RSR) in patients with stage IIIC–IV ovarian cancer (OC) undergone primary debulking surgery (PDS) vs. interval debulking surgery (IDS) after neoadjuvant... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical treatment for high-grade pseudomyxoma peritonei originated from appendix: Analysis of clinical outcomes of repeated debulking surgery
-
Park JH, Song I, Lee DW, Kwon YH, Kim JK, Moon SH, Park JW, Ryoo SB, Jeong SY, Park KJ
- KMID: 2369136
- Korean J Clin Oncol.
- 2016 Dec;12(2):119-123.
- doi: 10.14216/kjco.16020
PURPOSE: To evaluate the effect of repeated debulking surgery for high-grade pseudomyxoma peritonei (PMP) originating from the appendix. METHODS: Between January 1998 and December 2014, fifty patients, who underwent debulking surgery... -
- CITED
-
- Close
- SHARE
-
- Close
- Repair of diaphragmatic injury and placement of tube thoracostomy during right upper quadrant peritonectomy
-
Ozgul N, Basaran D, Boyraz G, Salman MC
- KMID: 2360236
- J Gynecol Oncol.
- 2016 Jan;27(1):e6.
- doi: 10.3802/jgo.2016.27.e6
OBJECTIVE: Patients with advanced or recurrent ovarian cancer often have metastatic disease in the upper abdominal region, especially to the right hemidiaphragm, which requires diaphragmatic resection in order to achieve... -
- CITED
-
- Close
- SHARE
-
- Close
- Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
-
Kim WR, Hur H, Min BS, Baik SH, Lee KY, Kim NK
- KMID: 2377385
- Ann Coloproctol.
- 2017 Feb;33(1):16-22.
- doi: 10.3393/ac.2017.33.1.16
PURPOSE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
-
Iwase H, Takada T, Iitsuka C, Nomura H, Abe A, Taniguchi , Takizawa K
- KMID: 2345921
- J Gynecol Oncol.
- 2015 Oct;26(4):303-310.
- doi: 10.3802/jgo.2015.26.4.303
OBJECTIVE: To investigate the clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery (IDS) in advanced epithelial ovarian cancer (EOC) patients. METHODS: We retrospectively reviewed the medical records of 124... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
-
So M, Miyamoto T, Murakami R, Abiko K, Hamanishi , Baba T, Mandai M
- KMID: 2458903
- J Gynecol Oncol.
- 2019 Nov;30(6):e100.
- doi: 10.3802/jgo.2019.30.e100
OBJECTIVE: In patients with recurrent ovarian cancer (ROC) in whom surgery is likely to render them disease-free, it is unclear whether secondary cytoreductive surgery (SCS) combined with chemotherapy is superior... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of lymphadenectomy for ovarian cancer
-
Mikami M
- KMID: 2130114
- J Gynecol Oncol.
- 2014 Oct;25(4):279-281.
- doi: 10.3802/jgo.2014.25.4.279
Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
-
Yoneoka Y, Ishikawa M, Uehara T, Shimizu H, Uno M, Murakami T, Kato T
- KMID: 2457157
- J Gynecol Oncol.
- 2019 Sep;30(5):e81.
- doi: 10.3802/jgo.2019.30.e81
OBJECTIVE: To treat advanced ovarian cancer, interval debulking surgery (IDS) is performed after 3 cycles each of neoadjuvant chemotherapy (NAC) and postoperative chemotherapy (IDS group). If we expect that complete... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Treatment of Macrodystrophia Lipomatosa Involving Superficial Peroneal Nerve in the Foot and Ankle
-
Kang SH, Shin SJ, Eho YJ
- KMID: 2421352
- J Korean Orthop Assoc.
- 2017 Dec;52(6):566-571.
- doi: 10.4055/jkoa.2017.52.6.566
Macrodystrophia lipomatosa is a congenital disease characterized by gradual proliferation in the mesenchymal cell, such as fibroadipose tissue. Pathologically, fatty tissue is deposited in the nerve sheath, periosteum, bone marrow,... -
- CITED
-
- Close
- SHARE
-
- Close
- Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
-
Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, Yang H
- KMID: 2374264
- J Gynecol Oncol.
- 2016 Nov;27(6):e62.
- doi: 10.3802/jgo.2016.27.e62
OBJECTIVE: Distal pancreatectomy with splenectomy may be required for optimal cytoreductive surgery in patients with epithelial ovarian cancer (EOC) metastasized to splenic hilum. This study evaluates the morbidity and treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
-
Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT
- KMID: 2417451
- J Gynecol Oncol.
- 2018 Jul;29(4):e63.
- doi: 10.3802/jgo.2018.29.e63
OBJECTIVE: The choice between primary debulking surgery (PDS) and neoadjuvant chemotherapy (NAC) in advanced ovarian cancer remains controversial. We evaluated NAC use in our center before and after results from... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
-
Liu YL, Filippova OT, Zhou Q, Iasonos A, Chi DS, Zivanovic O, Sonoda Y, Gardner GJ, Broach VA, O'Cearbhaill RE, Konner JA, Aghajanian C, Long Roche K, Tew WP
- KMID: 2465191
- J Gynecol Oncol.
- 2020 Jan;31(1):e17.
- doi: 10.3802/jgo.2020.31.e17
OBJECTIVE: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) confers similar outcomes as primary debulking surgery and chemotherapy. Little is known about patients who receive NACT but do not... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer
-
Zwakman N, van de Laar R, Van Gorp T, Zusterzeel PL, Snijders M, Ferreira I, Massuger L, Kruitwagen RF
- KMID: 2413854
- J Gynecol Oncol.
- 2017 Jan;28(1):e7.
- doi: 10.3802/jgo.2017.28.e7
OBJECTIVE: In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We wanted to examine the relationship... -
- CITED
-
- Close
- SHARE
-
- Close
